---All---
  • ---All---
  • Accession
  • Catalog #

ADD1 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP13986b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP13986b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

ADD1 Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP35611
Other AccessionNP_054909.2, NP_001110.2, NP_054908.2
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW80955 Da

ADD1 Antibody (C-term) - Additional info

Gene ID 118
Other Names
ADD1; ADDA; Alpha-adducin; Erythrocyte adducin subunit alpha
Target/Specificity
This ADD1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 604-634 amino acids from the C-terminal region of human ADD1.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
ADD1 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

ADD1 Antibody (C-term) - Protein Information

Name ADD1
Synonyms ADDA
Function
Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to calmodulin
Cellular Location
Cytoplasm, cytoskeleton. Cell membrane; Peripheral membrane protein; Cytoplasmic side
Tissue Location
Expressed in all tissues. Found in much higher levels in reticulocytes than the beta subunit

ADD1 Antibody (C-term) - Related products

AP13986b: ADD1 Antibody (C-term)

AP9518c: ADD1 Antibody (Center)

RI10136: ADD1 predesign siRNA

DC03630: Human ADD1 cDNA Clone

LY12219a: ADD1 Over-expression Lysate

BP9518c: ADD1 Antibody (Center) Blocking Peptide

AT1053a: ADD1 Antibody (monoclonal) (M01)

AJ1015a: Adducin alpha Antibody (C-term)

AJ1015b: Adducin alpha Antibody Phospho (pS481)

AJ1015c: Adducin alpha Antibody Phospho (pS59)

AE1003a: ADD1 Antibody (S726)

AE1003b: Phospho-ADD1-S726 Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Adducins are a family of cytoskeleton proteins encoded by three genes (alpha, beta, gamma). Adducin is a heterodimeric protein that consists of related subunits, which are produced from distinct genes but share a similar structure. Alpha- and beta-adducin include a protease-resistant N-terminal region and a protease-sensitive, hydrophilic C-terminal region. Alpha- and gamma-adducins are ubiquitously expressed. In contrast, beta-adducin is expressed at high levels in brain and hematopoietic tissues. Adducin binds with high affinity to Ca(2+)/calmodulin and is a substrate for protein kinases A and C. Alternative splicing results in multiple variants encoding distinct isoforms; however, not all variants have been fully described.

REFERENCES

Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Irvin, M.R., et al. J. Hypertens. 28(10):2076-2083(2010) Schuur, M., et al. J. Neurol. Neurosurg. Psychiatr. (2010) In press : Wang, Y., et al. Diabet. Med. 27(4):376-383(2010) Cross, D.S., et al. BMC Genet. 11, 51 (2010) :